Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aquaporin-9 is a membrane channel protein encoded by the AQP9 gene in humans. It belongs to the aquaglyceroporin subfamily within the major intrinsic protein family. Unlike classical aquaporins that primarily conduct water, Aquaporin-9 facilitates the passage of a broad range of noncharged solutes including glycerol, urea, lactate, purines, pyrimidines, arsenite, and possibly ammonium. It forms homotetrameric channels in cell membranes—each monomer acting independently—and is especially important for hepatic uptake of glycerol supporting gluconeogenesis. In addition to its metabolic roles in liver cells (hepatocytes), it may participate in specialized functions such as immunological responses by leukocytes and protection against arsenic toxicity through excretion pathways. The structure features six transmembrane domains with intracellular N- and C-termini typical for aquaporins.
Potential mechanisms for future drugs could include inhibition or modulation of channel activity to alter water/glycerol/solute flux across membranes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aquaporin-9 (AQP9).